Skip to main content
Journal cover image

TBCRC 001: EGFR inhibition with cetuximab in metastatic triple negative (basal-like) breast cancer

Publication ,  Conference
Carey, LA; Mayer, E; Marcom, PK; Rugo, H; Liu, M; Ma, C; Rimawi, M; Storniolo, A; Forero, A; Esteva, F; Wolff, A; Ingle, J; Ferraro, M ...
Published in: BREAST CANCER RESEARCH AND TREATMENT
December 1, 2007

Duke Scholars

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

December 1, 2007

Volume

106

Start / End Page

S32 / S32

Location

San Antonio, TX

Publisher

SPRINGER

Conference Name

30th Annual San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Carey, L. A., Mayer, E., Marcom, P. K., Rugo, H., Liu, M., Ma, C., … Winer, E. P. (2007). TBCRC 001: EGFR inhibition with cetuximab in metastatic triple negative (basal-like) breast cancer. In BREAST CANCER RESEARCH AND TREATMENT (Vol. 106, pp. S32–S32). San Antonio, TX: SPRINGER.
Carey, L. A., E. Mayer, P. K. Marcom, H. Rugo, M. Liu, C. Ma, M. Rimawi, et al. “TBCRC 001: EGFR inhibition with cetuximab in metastatic triple negative (basal-like) breast cancer.” In BREAST CANCER RESEARCH AND TREATMENT, 106:S32–S32. SPRINGER, 2007.
Carey LA, Mayer E, Marcom PK, Rugo H, Liu M, Ma C, et al. TBCRC 001: EGFR inhibition with cetuximab in metastatic triple negative (basal-like) breast cancer. In: BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2007. p. S32–S32.
Carey, L. A., et al. “TBCRC 001: EGFR inhibition with cetuximab in metastatic triple negative (basal-like) breast cancer.” BREAST CANCER RESEARCH AND TREATMENT, vol. 106, SPRINGER, 2007, pp. S32–S32.
Carey LA, Mayer E, Marcom PK, Rugo H, Liu M, Ma C, Rimawi M, Storniolo A, Forero A, Esteva F, Wolff A, Ingle J, Ferraro M, Sawyer L, Davidson N, Perou CM, Winer EP. TBCRC 001: EGFR inhibition with cetuximab in metastatic triple negative (basal-like) breast cancer. BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2007. p. S32–S32.
Journal cover image

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

December 1, 2007

Volume

106

Start / End Page

S32 / S32

Location

San Antonio, TX

Publisher

SPRINGER

Conference Name

30th Annual San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences